493
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Most important barriers and facilitators of HTA usage in decision-making in Europe

ORCID Icon, ORCID Icon, , , , , , , , & ORCID Icon show all
Pages 297-304 | Received 14 Nov 2017, Accepted 21 Dec 2017, Published online: 05 Jan 2018

References

  • Park AL, McDaid D, Weiser P, et al. Examining the cost effectiveness of interventions to promote the physical health of people with mental health problems: a systematic review. BMC Public Health. 2013;13:787. PubMed PMID: 23988266; PubMed Central PMCID: PMC3765875. DOI:10.1186/1471-2458-13-787
  • Nicod E, Kanavos P. Commonalities and differences in HTA outcomes: a comparative analysis of five countries and implications for coverage decisions. Health Policy. 2012;108(2):167–177.
  • Drummond MF, Schwartz JS, Jonsson B, et al. Key principles for the improved conduct of health technology assessments for resource allocation decisions. Int J Technol Assess Health Care. 2008 Summer;24(3): 244–258. discussion 362-8. PubMed PMID: 18601792; eng. DOI:10.1017/s0266462308080343
  • van Velden ME, Severens JL, Novak A. Economic evaluations of healthcare programmes and decision making. Pharmacoeconomics. 2005;23(11):1075–1082.
  • Oliver K, Innvar S, Lorenc T, et al. A systematic review of barriers to and facilitators of the use of evidence by policymakers. BMC Health Serv Res. 2014;14:2. PubMed PMID: 24383766; PubMed Central PMCID: PMC3909454. DOI:10.1186/1472-6963-14-2
  • Macintyre S, Chalmers I, Horton R, et al. Using evidence to inform health policy: case study. BMJ: Br Med J. 2001;322(7280):222.
  • Oortwijn W, Broos P, Vondeling H, et al. Mapping of health technology assessment in selected countries. Int J Technol Assess Health Care. 2013;29(04):424–434.
  • Garrido MV. Health technology assessment and health policy-making in Europe: current status, challenges and potential. WHO Region Office Euro. 2008;14:1–197.
  • Drummond M. Economic evaluation in health care: is it really useful or are we just kidding ourselves? Aust Econ Rev. 2004;37(1):3–11.
  • Neumann PJ. Why don’t Americans use cost-effectiveness analysis. Am J Manag Care. 2004;10(5):308–312.
  • Neumann PJ, Sullivan SD. Economic evaluation in the US. Pharmacoeconomics. 2006;24(11):1163–1168.
  • Prosser LA, Koplan JP, Neumann PJ, et al. Barriers to using cost-effectiveness analysis in managed care decision making. Am J Manag Care. 2000;6(2):173–179.
  • Cheung KL, Evers SMAA, de Vries H, et al. Most important barriers and facilitators regarding the use of Health Technology Assessment. Int J Technol Assess Health Care. 2017;33(2):1–9.
  • Mühlbacher AC, Kaczynski A, Zweifel P, et al. Experimental measurement of preferences in health and healthcare using best-worst scaling: an overview. Health Econ Rev. 2015;6(1):1–14.
  • Cheung KL, Wijnen BF, Hollin IL, et al. Using best–worst scaling to investigate preferences in health care. PharmacoEconomics. 2016;34(12):1195–1209.
  • Finn A, Louviere JJ. Determining the appropriate response to evidence of public concern: the case of food safety. J Public Policy Mark. 1992;11:12–25.
  • Flynn TN, Louviere JJ, Peters TJ, et al. Best–worst scaling: what it can do for health care research and how to do it. J Health Econ. 2007;26(1):171–189.
  • Marley AA, Louviere JJ. Some probabilistic models of best, worst, and best–worst choices. J Math Psychol. 2005;49(6):464–480.
  • Merlo G, Page K, Ratcliffe J, et al. Bridging the gap: exploring the barriers to using economic evidence in healthcare decision making and strategies for improving uptake. Appl Health Econ Health Policy. 2015;13:303–309.
  • Van Gool MK, Gallego G, Haas M, et al. Economic evidence at the local level. Pharmacoeconomics. 2007;25(12):1055–1062.
  • Williams I, Bryan S. Understanding the limited impact of economic evaluation in health care resource allocation: a conceptual framework. Health Policy. 2007;80(1):135–143.
  • Huić M, Nachtnebel A, Zechmeister I, et al. Collaboration in health technology assessment (EU net HTA JOINT ACTION, 2010–2012): four case studies. Int J Technol Assess Health Care. 2013;29(03):323–330.
  • Drummond M, Weatherly H. Implementing the findings of health technology assessments. Int J Technol Assess Health Care. 2000;16(01):1–12.
  • Hivon M, Lehoux P, Denis J-L, et al. Use of health technology assessment in decision making: coresponsibility of users and producers? Int J Technol Assess Health Care. 2005;21(02):268–275.
  • Stakes H, Rius ME, Espinas JA. EUR-ASSESS project subgroup report on dissemination and impact. Int J Technol Assess Health Care. 1997;13(2):220–286.
  • Brousselle A, Lessard C. Economic evaluation to inform health care decision-making: promise, pitfalls and a proposal for an alternative path. Soc Sci Med. 2011;72(6):832–839.
  • Hoffmann C, Stoykova BA, Nixon J, et al. Do health‐care decision makers find economic evaluations useful? The findings of focus group research in UK health authorities. Value Health. 2002;5(2):71–78.
  • Johnson RM. Understanding HB: an intuitive approach. Sequim (WA): Sawtooth Software Inc; 2000.
  • Orme B. Hierarchical Bayes: why all the attention? Quirk’s Mark Res Rev. 2000;14(3):16–63.
  • Sawtooth Software. Identifying ‘bad’ respondents: fit statistic and identifying random responders. 2016 [cited 2016 Jan 27]. Available from: https://www.sawtoothsoftware.com/help/issues/ssiweb/online_help/hid_web_maxdiff_badrespondents.htm
  • García-Mochón L, Balbino JE, de Labry Lima AO, et al. HTA and decision-making processes in Central, Eastern and South Eastern Europe: results from a survey. Health Policy. 2017. Available from:  https://www.ncbi.nlm.nih.gov/pubmed/?term=HTA+and+decision-making+processes+in+Central%2C+Eastern+and+South+Eastern+Europe%3A+results+from+a+survey
  • Hoffmann C, von der Schulenburg J-MG. The influence of economic evaluation studies on decision making. Europ Survey Health Policy. 2000;52(3):179–192.
  • Kristensen FB. Development of European HTA: from vision to EUnetHTA. Michael. 2012;9:147–156.
  • Mäkelä M, Rosén M, Jamtvedt G, et al. Cooperation is strength: joint achievements of the Nordic HTA centers. Michael. 2012;9:137–146.
  • Stephens JM, Handke B, Doshi JA. International survey of methods used in health technology assessment (HTA): does practice meet the principles proposed for good research. Comp Eff Res. 2012;2:29–44.
  • Cheung KL, Evers SM, Hiligsmann M, et al. Understanding the stakeholders’ intention to use economic decision-support tools: a cross-sectional study with the tobacco return on investment tool. Health Policy. 2016 Jan;120(1):46–54. PubMed PMID: 26718686; eng. DOI:10.1016/j.healthpol.2015.11.004
  • De Vries H. An integrated approach for understanding health behavior; the I-change model as an example. Psychol Behav Sci Int J. 2017;2(2):555–585.
  • Feig C, Cheung KL, Hiligsmann M, et al. Best-worst scaling to assess the most important barriers and facilitators for the use of health technology assessment in Austria. Expert Rev Pharmacoecon Outcomes Res. 2017 Sep 8:1–10. PubMed PMID: 28862060; eng. DOI:10.1080/14737167.2017.1375407

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.